Startups
CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects
Overview
Location
Austria, Vienna
Employees
11-50
Founded date
2018
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 30, 2026 | TAG Therapeutics announces publication in Nature Aging providing further evidence for efficacy of the TELOBLOCK approach | VIENNA, AUSTRIA, June 30, 2026 /EINPresswire.com/ -- TAG Therapeutics GmbH, a preclinical-stage biotechnology company dedicated to the development of precision medicine approaches for telomere pathologies and aging-related diseases, today a... |
| Mar 20, 2026 | Eveliqure and Serum Institute of India Announce Strategic Collaboration on the Development of Anti-Diarrhoeal Vaccines | VIENNA, AUSTRIA, March 20, 2026 /EINPresswire.com/ -- Eveliqure Biotechnologies GmbH, a clinical-stage biotechnology company focused on Shigella and ETEC vaccine development, and Serum Institute of India (SII), a Cyrus Poonawalla group comp... |
| Jul 23, 2025 | Eveliqure Announces Dosing of First Participants in a Phase 2b study of the ShigETEC Vaccine in Shigellosis | VIENNA, AUSTRIA, July 23, 2025 /EINPresswire.com/ -- • Phase 2b study to assess immunogenicity and efficacy of the oral ShigETEC vaccine against Shigellosis • Study entails vaccination of participants followed by a Controlled Human Infectio... |
| Dec 11, 2024 | CEBINA and Danube BioVentures announce the launch of TAG Therapeutics developing a new approach for telomere pathologies | VIENNA, AUSTRIA, December 11, 2024 /EINPresswire.com/ -- Danube Labs, a life science acceleration partnership formed by CEBINA GmbH (Central European Biotech Incubator and Accelerator), Evotec SE and the biotech fund Danube BioVentures, ann... |
| Sep 17, 2024 | CEBINA and Charles River Laboratories announce strategic collaboration to accelerate neuroscience research | VIENNA, VIENNA, AUSTRIA, September 17, 2024 /EINPresswire.com/ -- CEBINA GmbH, Central European Biotech Incubator and Accelerator, and Charles River Laboratories International, Inc. (NYSE: CRL), announce today a strategic collaboration with... |
| Feb 28, 2024 | CEBINA announces the launch of DanubeNeuro, an acceleration program for innovative neuroscience research | VIENNA, AUSTRIA, February 28, 2024 /EINPresswire.com/ -- CEBINA GmbH, Central European Biotech Incubator and Accelerator, announces today the launch of the DanubeNeuro program advancing breakthrough innovative academic research projects in ... |
| Jul 4, 2022 | CEBINA publishes data demonstrating the anti-histamine azelastine inhibits infection by major variants of SARS-CoV-2 | VIENNA, VIENNA, AUSTRIA, July 4, 2022 /EINPresswire.com/ -- CEBINA GmbH, Central European Biotech Incubator and Accelerator, today announces the publication of research results demonstrating that the commonly used anti-histamine, azelastine... |
| Jun 14, 2021 | EVOTEC SE Evotec : partners with CEBINA to launch Danube Labs, a partnership to develop cutting edge biotechnology projects sourced from Central and Eastern European Universities and Research Institutions | Vienna, Austria, 14 June 2021: CEBINA GmbH, Central European Biotech Incubator and Accelerator, today announces the launch of Danube Labs, a partnership with Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) to fast... |
Reviews 0
FAQ about CEBINA
When was CEBINA founded?
CEBINA was founded in 2018.
What has the press written about CEBINA?
Parsers VC has collected 9 articles mentioning CEBINA, among them “TAG Therapeutics announces publication in Nature Aging providing further evidence for efficacy of the TELOBLOCK approach” (Jun 30, 2026) and “Eveliqure and Serum Institute of India Announce Strategic Collaboration on the Development of Anti-Diarrhoeal Vaccines” (Mar 20, 2026).
Is CEBINA still active?
Yes, CEBINA is active; its latest activity on Parsers VC dates from Aug 20, 2026.